• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JON BATES AS ITS NEW CHIEF FINANCIAL OFFICER

    6/10/22 6:00:00 AM ET
    $NUTX
    $USPH
    Real Estate
    Real Estate
    Medical/Nursing Services
    Health Care
    Get the next $NUTX alert in real time by email

    HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022.

    On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee.  On June 8, 2022, the Company announced the appointment of Jon Bates as the Company's new Chief Financial Officer, effective on or about June 30, 2022. Mr. Bowen will remain employed with the Company for the purpose of providing transition and other consulting services for an additional twelve months.

    Mr. Bates, age 52, is an experienced and proactive finance leader with a CPA and MBA. Since 2006, he has served as Vice President of Accounting and Corporate Controller at U.S. Physical Therapy, Inc. (NYSE:USPH), one of the largest publicly traded, pure-play national operators of outpatient physical therapy clinics and provider of industrial injury prevention services.

    Among his many successes, Mr. Bates improved overall accuracy by monitoring the monthly, quarterly and yearly end closing process for 600+ locations with $500+ million in annual revenues. They are located within 39 states and 6 regions and comprised of 145+ legal partnerships. He ensured maximum profitability and reliability by directing and leading a team of 35 employees, including 6 regional controllers, and controlled merger and acquisition tasks from valuation/modeling to due diligence and integration post-acquisition. Prior to U.S. Physical Therapy, he served as Chief Financial Officer and Chief Accounting Officer at Commerciant, L.P., Chief Accounting Officer and Corporate Controller at National Alarm Technologies LLC, Assistant Corporate Controller at American Residential Services, Inc. and Experienced Senior Auditor at Arthur Andersen LLP. His areas of expertise include strategic planning, risk assessment and evaluation, internal audit/SOX reporting, valuation and deal acquisition.

    Mr. Bates holds a BBA from the University of Texas at Austin and a MBA from the University of Houston. He is also a Certified Public Accountant.

    "Nutex Health is a leader in the micro hospital and population health management industry," stated Jon Bates, incoming Chief Financial Officer of Nutex Health.  "I am excited to join Nutex's passionate executive team."

    "We are excited to have Jon join our team," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health. "He brings excellent credentials in the public markets, a proven track record of financial stewardship and strong operational skills."

    "Jon will be an asset to the Company as we continue to execute on our growth initiatives. We welcome him to the executive management team," stated Warren Hosseinion, M.D., President of Nutex Health.

    About Nutex Health Inc. (Combined post-merger company)

    Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a physician-led, technology-enabled healthcare services company with approximately 1500 employees nationwide and is partnered with over 800 physicians. The Company has two divisions: a Hospital division and a Population Health Management division. The Hospital division owns and operates 21 facilities in eight different states. The division implements and operates different innovative health care models, including micro hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organizations (MSOs), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently. 

    Safe Harbor:

    Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company.  Such uncertainties and risks include the ability to realize the anticipated benefits of the transaction, significant transaction costs and unknown liabilities and litigation and regulatory risks related to the transaction.   In addition, forward-looking statements are subject to additional uncertainties and risks facing the Company, including but not limited to, economic conditions, dependence on management, dilution to stockholders, lack of capital, changes in laws or regulations, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's  ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

     

    Cision View original content:https://www.prnewswire.com/news-releases/nutex-health-announces-the-appointment-of-jon-bates-as-its-new-chief-financial-officer-301565610.html

    SOURCE Nutex Health, Inc.

    Get the next $NUTX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NUTX
    $USPH

    CompanyDatePrice TargetRatingAnalyst
    U.S. Physical Therapy Inc.
    $USPH
    9/18/2025$110.00Overweight
    Analyst
    U.S. Physical Therapy Inc.
    $USPH
    12/16/2024$100.00 → $115.00Neutral → Buy
    BofA Securities
    U.S. Physical Therapy Inc.
    $USPH
    12/16/2024$113.00Mkt Outperform
    JMP Securities
    Nutex Health Inc.
    $NUTX
    11/12/2024$45.00 → $50.00Buy
    Maxim Group
    U.S. Physical Therapy Inc.
    $USPH
    10/7/2024$114.00 → $90.00Buy → Neutral
    BofA Securities
    Nutex Health Inc.
    $NUTX
    9/18/2024$45.00Buy
    Maxim Group
    U.S. Physical Therapy Inc.
    $USPH
    9/22/2023$108.00Overweight
    JP Morgan
    U.S. Physical Therapy Inc.
    $USPH
    6/30/2023$138.00Buy
    BofA Securities
    More analyst ratings

    $NUTX
    $USPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

    Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%Net income attributable to Nutex Health Inc. of $59.0 million for the first nine months of 2025 versus net loss of $9.5 million for the first nine months of 2024, an increase of $68.5 millionDiluted income per share of $8.87 for the first nine months of 2025 versus a loss per share of $1.91 for the first nine months of 2024EBITDA of $142.9 million for the first nine months of 2025 versus $19.9 million for the first nine months of 2024, an increase of 616.4%Adjusted EBITDA of $243.0 million for the first nine months of 2025 versus $16.1 million for th

    11/19/25 4:30:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

    Total revenue of $455.8 million for the first half of 2025 versus $143.5 million for the first half of 2024, an increase of 217.5%Net income attributable to Nutex Health Inc. of $3.5 million for the first half of 2025 versus net loss of $0.7 million for the first half of 2024, an increase of $4.2 millionDiluted income per share of $0.55 for the first half of 2025 versus a loss per share of $0.15 for the first half of 2024EBITDA of $51.1 million for the first half of 2025 versus $15.6 million for the first half of 2024, an increase of 227.4%Adjusted EBITDA of $144.4 million for the first half of 2025 versus $6.4 million for the first half of 2024, an increase of 2144.2%Net cash from operating

    11/18/25 6:59:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS

    Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0%Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 million for Q1 2024, an increase of $21.6 million.Diluted income per share of $3.33 for Q1 2025 versus a loss per share of $0.08 for Q1 2024EBITDA of $51.5 million for Q1 2025 versus $7.1 million for Q1 2024, an increase of 624.7%Adjusted EBITDA of $72.8 million for Q1 2025 versus $(0.4) million for Q1 2024, an increase of $73.2 millionNet cash from operating activities of $51.0 million for Q1 2025The Company believes its arbitration efforts through the Independent Dispute Resolution (IDR) process

    11/18/25 6:50:00 PM ET
    $NUTX
    Real Estate

    $NUTX
    $USPH
    SEC Filings

    View All

    Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    11/19/25 4:07:53 PM ET
    $NUTX
    Real Estate

    SEC Form 10-Q filed by Nutex Health Inc.

    10-Q - Nutex Health, Inc. (0001479681) (Filer)

    11/19/25 4:07:19 PM ET
    $NUTX
    Real Estate

    Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    11/18/25 5:00:07 PM ET
    $NUTX
    Real Estate

    $NUTX
    $USPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on U.S. Physical Therapy with a new price target

    Analyst resumed coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $110.00

    9/18/25 8:45:48 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy upgraded by BofA Securities with a new price target

    BofA Securities upgraded U.S. Physical Therapy from Neutral to Buy and set a new price target of $115.00 from $100.00 previously

    12/16/24 6:45:03 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    JMP Securities initiated coverage on U.S. Physical Therapy with a new price target

    JMP Securities initiated coverage of U.S. Physical Therapy with a rating of Mkt Outperform and set a new price target of $113.00

    12/16/24 6:39:42 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $NUTX
    $USPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bates Jon Christian converted options into 1,611 shares and bought $81,810 worth of shares (1,000 units at $81.81), increasing direct ownership by 115% to 4,888 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    4/14/25 4:30:48 PM ET
    $NUTX
    Real Estate

    Director Gilmartin Kathleen A bought $172,180 worth of shares (2,000 units at $86.09), increasing direct ownership by 12% to 18,904 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/3/24 6:38:08 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Bates Jon Christian bought $28,970 worth of shares (1,350 units at $21.46), increasing direct ownership by 146% to 2,277 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    8/26/24 11:54:30 AM ET
    $NUTX
    Real Estate

    $NUTX
    $USPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Bamburg Wesley Shane

    3 - Nutex Health, Inc. (0001479681) (Issuer)

    10/23/25 12:44:57 PM ET
    $NUTX
    Real Estate

    Director Ham Nancy sold $49,026 worth of shares (600 units at $81.71), decreasing direct ownership by 23% to 1,994 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/11/25 4:51:38 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    President and COO Williams Eric Joseph sold $85,250 worth of shares (1,000 units at $85.25), decreasing direct ownership by 4% to 25,331 units (SEC Form 4)

    4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)

    9/8/25 4:15:06 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $NUTX
    $USPH
    Financials

    Live finance-specific insights

    View All

    NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

    Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%Net income attributable to Nutex Health Inc. of $59.0 million for the first nine months of 2025 versus net loss of $9.5 million for the first nine months of 2024, an increase of $68.5 millionDiluted income per share of $8.87 for the first nine months of 2025 versus a loss per share of $1.91 for the first nine months of 2024EBITDA of $142.9 million for the first nine months of 2025 versus $19.9 million for the first nine months of 2024, an increase of 616.4%Adjusted EBITDA of $243.0 million for the first nine months of 2025 versus $16.1 million for th

    11/19/25 4:30:00 PM ET
    $NUTX
    Real Estate

    U.S. Physical Therapy Reports Third Quarter 2025 Results

    U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $23.9 million for the three months ended September 30, 2025 ("2025 Third Quarter"), an increase of $2.8 million, or 13.2%, from $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter") primarily driven by clinic additions. Net income attributable to USPH shareholders ("USPH Net Incom

    11/5/25 5:00:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    U.S. Physical Therapy, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call Dates

    U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and nine months ended September 30, 2025, on Wednesday, November 5, 2025, after the stock market closes, with the conference call to follow the next morning, on Thursday, November 6, 2025. Conference Call   Date:   Thursday, November 6, 2025     Time:   10:30 am Eastern / 9:30 am Central     Dial-In Number:   (800) 245-3047 Primary or         (203) 518-9765 Alternate     Conference ID

    10/22/25 8:30:00 AM ET
    $USPH
    Medical/Nursing Services
    Health Care

    $NUTX
    $USPH
    Leadership Updates

    Live Leadership Updates

    View All

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER

    HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments  in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Wesley Bamburg as the Company's Chief Operating Officer, effective October 13, 2025. Mr. Bamburg is an accomplished healthcare executive with 20 years of Fortune 500 experience in healthcare operations, business development, integrated network management, and physician relations. Mr. Bamburg has served as Chief Operating Officer for HCA Houst

    9/22/25 6:30:00 AM ET
    $NUTX
    Real Estate

    U.S. Physical Therapy Announces Dual Listing on NYSE Texas

    U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being

    5/28/25 4:10:00 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR

    HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the

    5/22/25 6:30:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    $USPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    11/14/24 11:02:17 AM ET
    $NUTX
    Real Estate

    Amendment: SEC Form SC 13G/A filed by U.S. Physical Therapy Inc.

    SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    11/13/24 4:05:19 PM ET
    $USPH
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by U.S. Physical Therapy Inc.

    SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)

    10/22/24 3:57:52 PM ET
    $USPH
    Medical/Nursing Services
    Health Care